510(k) K230349
K230349 is an FDA 510(k) premarket notification submitted by Quidel Corporation for the device "Lyra RSV+hMPV Assay". The FDA issued a decision of Substantially Equivalent on March 10, 2023. The device falls under product code OEM (Human Metapneumovirus (Hmpv) Rna Assay System), a Class II device regulated under 21 CFR 866.3980. Quidel Corporation has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 10, 2023
- Date Received
- February 9, 2023
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Human Metapneumovirus (Hmpv) Rna Assay System
- Device Class
- Class II
- Regulation Number
- 866.3980
- Review Panel
- MI
- Submission Type
A qualitative in vitro diagnostic assay intended to detect human metapneumovirus (hmpv) rna extracted from human respiratory specimens or viral cultures. Detection of hmpv rna aids in the diagnosis of respiratory hmpv infection in conjunction with other clinical and laboratory testing in patients exhibiting signs and symptoms of upper respiratory tract infections.